Joseph C Papa has bought stock on 7 days since Jun 2016

Joseph C. Papa is an American healthcare executive with over 35 years of experience in the pharmaceutical and life sciences industries, currently serving as President and Chief Executive Officer of Emergent BioSolutions Inc. (NYSE: EBS).( Appointed to lead Emergent in February 2024, he is responsible for driving the company’s multi-year transformation strategy and overseeing its portfolio of medical countermeasures and specialty biologics that protect public health.( Papa has also been recognized for his ability to guide companies through complex turnarounds and periods of significant change.(

Prior to Emergent, Papa served as chairman and CEO of Bausch Health Companies Inc. and later as CEO and chairman of Bausch + Lomb Corporation, where he led the eye health business through its initial public offering on the NYSE in 2022.( He previously held chief executive and senior leadership roles at Perrigo, Cardinal Health, Watson Pharmaceuticals, DuPont Pharmaceuticals, Searle/Pharmacia, and Novartis, gaining broad operational and commercial experience across generic, branded, and specialty pharmaceuticals.( In addition to his Emergent role, Papa serves as chairman of SparingVision and sits on the boards of Candel Therapeutics and Milestone Pharmaceuticals, reflecting his ongoing influence across global biopharmaceutical and genomic medicine companies.( He holds a B.S. in pharmacy from the University of Connecticut and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management.(

Written by Perplexity from public sources.